Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Macitentant–tadalafil for treating pulmonary arterial hypertension TS ID 10517Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Macitentan for treating pulmonary arterial hypertension in people 1 month to 17 years TS ID 11805Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertensionStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC